Ηνωμένο Βασίλειο - Αγγλικά - MHRA (Medicines & Healthcare Products Regulatory Agency)

dawa ltd - cyanocobalamin - oral tablet - 50microgram

Ηνωμένο Βασίλειο - Αγγλικά - MHRA (Medicines & Healthcare Products Regulatory Agency)

p.i.e. pharma ltd - cyanocobalamin - oral tablet - 50microgram

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204) - cyanocobalamin 1000 ug in 1 ml - cyanocobalamin is indicated for vitamin b12 deficiencies due to malabsorption which may be associated with the following conditions: addisonian (pernicious) anemia gastrointestinal pathology, dysfunction, or surgery, including gluten enteropathy or sprue, small bowel bacteria overgrowth, total or partial gastrectomy fish tapeworm infestation malignancy of pancreas or bowel folic acid deficiency it may be possible to treat the underlying disease by surgical correction of anatomic lesions leading to small bowel bacterial overgrowth, expulsion of fish tapeworm, discontinuation of drugs leading to vitamin malabsorption (see drug interactions ), use of a gluten-free diet in nontropical sprue, or administration of antibiotics in tropical sprue. such measures remove the need for long-term administration of cyanocobalamin. requirements of vitamin b12 in excess of normal (due to pregnancy, thyrotoxicosis, hemolytic anemia, hemorrhage, malignancy, hepatic and renal disease) can usually be met with oral supplementation. cyanocobalamin injection, usp is also suitable for the vitamin b12 absorption test (schilling test ). sensitivity to cobalt and/or vitamin b12 is a contraindication.

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

fresenius kabi usa, llc - cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204) - cyanocobalamin 1000 ug in 1 ml - cyanocobalamin is indicated for vitamin b12 deficiencies due to malabsorption which may be associated with the following conditions:             addisonian (pernicious) anemia             gastrointestinal pathology, dysfunction, or surgery, including gluten enteropathy or sprue, small bowel bacterial overgrowth, total or partial gastrectomy             fish tapeworm infestation             malignancy of pancreas or bowel             folic acid deficiency it may be possible to treat the underlying disease by surgical correction of anatomic lesions leading to small bowel bacterial overgrowth, expulsion of fish tapeworm, discontinuation of drugs leading to vitamin malabsorption (see drug/laboratory test interactions ), use of a gluten-free diet in nontropical sprue, or administration of antibiotics in tropical sprue.  such measures remove the need for long-term administration of cyanocobalamin. requirements of vitamin b12 in excess of normal (due to pregnancy, thyrotoxicosis, hemolytic anemia, hemorrhage, ma

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

american regent, inc. - cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204) - cyanocobalamin 1000 ug in 1 ml - cyanocobalamin is indicated for vitamin b12 deficiencies due to malabsorption which may be associated with the following conditions: -  addisonian (pernicious) anemia -  gastrointestinal pathology, dysfunction, or surgery, including gluten enteropathy or sprue, small bowel bacteria overgrowth, total or partial gastrectomy -  fish tapeworm infestation -  malignancy of pancreas or bowel -  folic acid deficiency it may be possible to treat the underlying disease by surgical correction of anatomic lesions leading to small bowel bacterial overgrowth, expulsion of fish tapeworm, discontinuation of drugs leading to vitamin malabsorption (see drug interactions ), use of a gluten-free diet in nontropical sprue, or administration of antibiotics in tropical sprue. such measures remove the need for long-term administration of cyanocobalamin. requirements of vitamin b12 in excess of normal (due to pregnancy, thyrotoxicosis, hemolytic anemia, hemorrhage, malignancy, hepatic and renal disease) can usually be met with oral

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

physicians total care, inc. - cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204) - cyanocobalamin 1000 ug in 1 ml - cyanocobalamin is indicated for vitamin b12 deficiencies due to malabsorption which may be associated with the following conditions: it may be possible to treat the underlying disease by surgical correction of anatomic lesions leading to small bowel bacterial overgrowth, expulsion of fish tapeworm, discontinuation of drugs leading to vitamin malabsorption (see drug interactions ), use of a gluten-free diet in nontropical sprue, or administration of antibiotics in tropical sprue. such measures remove the need for long-term administration of cyanocobalamin. requirements of vitamin b12 in excess of normal (due to pregnancy, thyrotoxicosis, hemolytic anemia, hemorrhage, malignancy, hepatic and renal disease) can usually be met with oral supplementation. cyanocobalamin injection, usp is also suitable for the vitamin b12 absorption test ( schilling test). sensitivity to cobalt and/or vitamin b12 is a contraindication.

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

actavis pharma, inc. - hydroxocobalamin acetate (unii: s535m27n3q) (hydroxocobalamin - unii:q40x8h422o) - hydroxocobalamin 1000 ug in 1 ml - - pernicious anemia, both uncomplicated and accompanied by nervous system involvement. pernicious anemia, both uncomplicated and accompanied by nervous system involvement. - dietary deficiency of vitamin b12 , occurring in strict vegetarians and in their breast-fed infants. (isolated vitamin b12 deficiency is very rare). dietary deficiency of vitamin b12 , occurring in strict vegetarians and in their breast-fed infants. (isolated vitamin b12 deficiency is very rare). - malabsorption of vitamin b12 , resulting from structural or functional damage to the stomach, where intrinsic factor is secreted or to the ileum, where intrinsic factor facilitates vitamin b12 absorption. these conditions include tropical sprue, and nontropical sprue (idiopathic steatorrhea, gluten-induced enteropathy). folate deficiency in these patients is usually more severe than vitamin b12 deficiency. malabsorption of vitamin b12 , resulting from structural or functional damage to the stomach, where intrinsic factor is secreted or to the ileum, where intrinsic factor facilitates vitamin b12 absorption. these conditions include tropical sprue, and nontropical sprue (idiopathic steatorrhea, gluten-induced enteropathy). folate deficiency in these patients is usually more severe than vitamin b12 deficiency. - inadequate secretion of intrinsic factor, resulting from lesions that destroy the gastric mucosa (ingestion of corrosives, extensive neoplasia), and a number of conditions associated with a variable degree of gastric atrophy (such as multiple sclerosis, certain endocrine disorders, iron deficiency, and subtotal gastrectomy). total gastrectomy always produces vitamin b12 deficiency. structural lesions leading to vitamin b12 deficiency include regional ileitis, ileal resections, malignancies, etc. inadequate secretion of intrinsic factor, resulting from lesions that destroy the gastric mucosa (ingestion of corrosives, extensive neoplasia), and a number of conditions associated with a variable degree of gastric atrophy (such as multiple sclerosis, certain endocrine disorders, iron deficiency, and subtotal gastrectomy). total gastrectomy always produces vitamin b12 deficiency. structural lesions leading to vitamin b12 deficiency include regional ileitis, ileal resections, malignancies, etc. - competition for vitamin b12 by intestinal parasites or bacteria. the fish tapeworm (diphyllobothrium latum) absorbs huge quantities of vitamin b12 and infested patients often have associated gastric atrophy. the blind-loop syndrome may produce deficiency of vitamin b12 or folate. competition for vitamin b12 by intestinal parasites or bacteria. the fish tapeworm (diphyllobothrium latum) absorbs huge quantities of vitamin b12 and infested patients often have associated gastric atrophy. the blind-loop syndrome may produce deficiency of vitamin b12 or folate. - inadequate utilization of vitamin b12 . this may occur if antimetabolites for the vitamin are employed in the treatment of neoplasia. inadequate utilization of vitamin b12 . this may occur if antimetabolites for the vitamin are employed in the treatment of neoplasia. - for the schilling test. for the schilling test.

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

somerset therapeutics, llc - cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204) - cyanocobalamin 1000 ug in 1 ml - cyanocobalamin is indicated for vitamin b12 deficiencies due to malabsorption which may be associated with the following conditions: addisonian (pernicious) anemia gastrointestinal pathology, dysfunction, or surgery, including gluten enteropathy or sprue, small bowel bacterial overgrowth, total or partial gastrectomy fish tapeworm infestation malignancy of pancreas or bowel folic acid deficiency it may be possible to treat the underlying disease by surgical correction of anatomic lesions leading to small bowel bacterial overgrowth, expulsion of fish tapeworm, discontinuation of drugs leading to vitamin malabsorption (see drug/laboratory test interactions ), use of a gluten-free diet in nontropical sprue, or administration of antibiotics in tropical sprue. such measures remove the need for long-term administration of cyanocobalamin. requirements of vitamin b12 in excess of normal (due to pregnancy, thyrotoxicosis, hemolytic anemia, hemorrhage, malignancy, hepatic and renal disease) can usually be met with oral supplementation. cyanocobalamin injection is also suitable for the vitamin b12 absorption test (schilling test). sensitivity to cobalt and/or vitamin b12 is a contraindication.

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

general injectables & vaccines, inc - cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204) - cyanocobalamin 1000 ug in 1 ml - cyanocobalamin is indicated for vitamin b12 deficiencies due to malabsorption which may be associated with the following conditions:       addisonian (pernicious) anemia     gastrointestinal pathology, dysfunction, or surgery, including gluten enteropathy or sprue, small bowel bacteria overgrowth, total or partial gastrectomy     fish tapeworm infestation     malignancy of pancreas or bowel     folic acid deficiency it may be possible to treat the underlying disease by surgical correction of anatomic lesions leading to small bowel bacterial overgrowth, expulsion of fish tapeworm, discontinuation of drugs leading to vitamin malabsorption (see drug interactions), use of a gluten-free diet in nontropical sprue, or administration of antibiotics in tropical sprue. such measures remove the need for long-term administration of cyanocobalamin. requirements of vitamin b12 in excess of normal (due to pregnancy, thyrotoxicosis, hemolytic anemia, hemorrhage, malignancy, hepatic and renal disease) can usually be met with

Μάλτα - Αγγλικά - Medicines Authority

lannacher heilmittel ges.m.b.h 8502 lannach, austria - cyanocobalamin, pyridoxine hydrochloride, thiamine hydrochloride - film-coated tablet - cyanocobalamin 0.2 mg pyridoxine hydrochloride 200 mg thiamine hydrochloride 100 mg - vitamins